Simcere Pharmaceutical Group Limited Stock
Stocks
2096
HK0000658531
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Hong Kong S.E.
12:08:35 15/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 10.83 HKD | -0.46% |
|
-1.37% | -9.52% |
| 10-13 | Major drugmakers turn to China for licensing deals | RE |
| 10-02 | Major drugmakers turn to China for licensing deals | RE |
| Market Cap | 3.54B 27.81B 3.16B 2.94B 2.67B 5.03B 336B 5.12B 35.32B 13.82B 175B 13.3B 13.02B 560B | P/E 2026 * |
13.4x | P/E 2027 * | 11.6x |
|---|---|---|---|---|---|
| Enterprise Value | 3.35B 26.27B 2.99B 2.78B 2.53B 4.75B 317B 4.84B 33.35B 13.05B 165B 12.56B 12.29B 529B | EV / Sales 2026 * |
2.22x | EV / Sales 2027 * | 1.94x |
| Free-Float |
33.7% | Yield 2026 * |
3.9% | Yield 2027 * | 4.43% |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 2096 | Delayed | |
OTC Markets
| SMHG.F | Delayed | |
|
Tradegate
| S2P | Real-time | |
|
Deutsche Boerse AG
| S2P | Delayed | |
|
Börse Stuttgart
| S2P | Delayed | |
|
Boerse Muenchen
| S2P | Real-time |
| 1 day | -0.46% | ||
| 1 week | -1.37% | ||
| Current month | -8.61% | ||
| 1 month | -3.73% | ||
| 3 months | -16.63% | ||
| 6 months | -22.48% | ||
| Current year | -9.52% |
| 1 week | 10.5 |  | 11.05 |
| 1 month | 10.5 | | 11.89 |
| Current year | 9.07 | | 14.28 |
| 1 year | 9.07 | | 14.38 |
| 3 years | 4.94 | | 15.08 |
| 5 years | 4.94 | | 15.08 |
| 10 years | 4.94 | | 15.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jinsheng Ren
CEO | Chief Executive Officer | 63 | 20/08/2026 |
Yunshu Zhou
CEO | Chief Executive Officer | 54 | 25/03/2026 |
Yushan Wan
DFI | Director of Finance/CFO | 55 | 19/11/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Jinsheng Ren
CHM | Chairman | 63 | 08/10/2012 |
Yushan Wan
BRD | Director/Board Member | 55 | 19/11/2019 |
Renhong Tang
BRD | Director/Board Member | 46 | 01/11/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/08/26 | Other | Chairperson | -3,000,000 | 0.1168% | ||
| 13/07/26 | Other | Founder | -47,000 | 0.0018% | ||
| 13/07/26 | Other | Director | -47,000 | 0.0018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.46% | -1.37% | -11.66% | +60.68% | 3.56B | |
| +3.55% | +7.01% | +51.42% | +105.45% | 1,077B | |
| -0.25% | -1.25% | +32.49% | +61.48% | 612B | |
| +0.59% | +4.03% | +25.28% | +91.54% | 501B | |
| -1.48% | +1.97% | +72.62% | +39.59% | 364B | |
| +2.37% | +7.66% | +33.65% | +48.87% | 353B | |
| +2.64% | +6.95% | +21.01% | +43.85% | 278B | |
| +3.24% | +6.78% | +0.43% | +15.71% | 251B | |
| +1.86% | +6.53% | +45.98% | +52.77% | 230B | |
| +2.49% | +6.98% | +33.03% | +102.67% | 190B | |
| Average | +1.46% | +3.34% | +30.42% | +62.26% | 386.01B | |
| Weighted average by Cap. | +1.74% | +4.11% | +38.60% | +71.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.51B 11.84B 1.35B 1.25B 1.14B 2.14B 143B 2.18B 15.04B 5.89B 74.59B 5.66B 5.54B 239B | 1.76B 13.79B 1.57B 1.46B 1.33B 2.49B 166B 2.54B 17.51B 6.85B 86.83B 6.59B 6.45B 278B |
| Net income | 257M 2.01B 229M 213M 194M 364M 24.31B 371M 2.56B 1B 12.69B 963M 943M 40.59B | 303M 2.38B 271M 252M 229M 431M 28.74B 439M 3.02B 1.18B 15B 1.14B 1.11B 47.99B |
| Net Debt | -197M -1.55B -176M -164M -149M -280M -18.69B -285M -1.97B -769M -9.75B -740M -725M -31.2B | -140M -1.1B -125M -116M -105M -198M -13.24B -202M -1.39B -545M -6.91B -524M -513M -22.1B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/10/26 | HK$10.83 | -0.46% | 3,387,000 |
| 14/10/26 | HK$10.88 | +1.49% | 2,487,000 |
| 13/10/26 | HK$10.72 | -1.65% | 5,233,215 |
| 12/10/26 | HK$10.90 | +0.09% | 1,771,000 |
| 09/10/26 | HK$10.89 | -0.82% | 4,810,000 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 2096 Stock
Select your edition
All financial news and data tailored to specific country editions
